Novel medical technologies and drug platforms such as mRNA and lipid nanoparticles are revolutionizing healthcare, with applications in such critical areas as cancer treatment, rare diseases, and novel vaccines. We are honored to have join us today three recipients of the international Tang Prize in Biopharmaceutical Science, awarded for their role in developing mRNA vaccines, to examine what the future holds for these exciting new technologies. Join us for a thought-provoking and informative session on the cutting edge of drug development technologies.
09:00 – 10:30 | Session 1 (Plenary) – Global Biotech Development |
---|---|
09:00 – 09:05 | Welcome
Johnsee Lee, Chairman of BIO Asia–Taiwan 2023 |
09:05 – 09:15 | Opening Address |
09:15 – 09:20 | VIP Remarks
Chung-Hsiun Wu, Chairman, Taiwan Bio Industry Organization |
09:20 – 09:30 | Opening Ceremony for Conference |
09:30 – 09:45 | Nucleoside-modified mRNA-LNP Therapeutics
Drew Weissman, Professor, University of Pennsylvania, 2022 Tang Prize Laureate |
09:45 – 10:00 | Design of Lipid Nanoparticles That Enable Gene Therapies
Pieter Cullis, Professor, University of British Columbia, 2022 Tang Prize Laureate |
10:00 – 10:15 | Developing mRNA for Therapy
Katalin Karikó, Professor of University of Pennsylvania and senior vice president of BioNTech RNA Pharmaceuticals, 2022 Tang Prize Laureate |
10:15 – 10:25 | Break |